Results 231 to 240 of about 118,975 (293)

Pharmaceutical interventions in self-medication: A descriptive study in community pharmacies. [PDF]

Explor Res Clin Soc Pharm
Bedhomme S, Pradeleix P, Martinet E, Ramos I, Martineau D, Lafarge E, Pereton B, Savanovitch C.   +7 more
europepmc   +1 more source

“It's the Exact Same Treatment … Except Only 5 Min Away”: A RE‐AIM Evaluation of a Speech‐Language Pathology Shared‐Care Model for Rural Patients With Head and Neck Cancer

Head &Neck, EarlyView.
ABSTRACT Background Challenges accessing post‐treatment speech‐language pathology (SLP) services can add to treatment burden for rural patients with head and neck cancer (HNC). Hence, the aim of this study was to evaluate a shared‐care SLP service designed to support local SLP access for patients with HNC, using the RE‐AIM framework.
Corey Patterson, Elizabeth C. Ward, Rebecca L. Packer, Jasmine Foley, Laurelie R. Wishart, Clare L. Burns, Sally Pether, Wendy Comben   +7 more
wiley   +1 more source

Why Diamond Open Access Matters: A Call to ENT Researchers

Turkish Archives of Otorhinolaryngology
Taner Kemal Erdağ
doaj   +1 more source

Secondary polymicrobial infection of a giant nasal pyogenic granuloma with <i>Pasteurella multocida</i>: A case report. [PDF]

IDCases
Kimura T, Kimura E, Kuwazoe H, Hayata S, Ozaki T, Kaneko F, Iwai-Kumashiro N, Kinoshita T, Shiga T, Sakatani H, Murakami D, Hotomi M, Kono M.   +12 more
europepmc   +1 more source

Incidence and Site‐Specific Risk Factors of Jaw Osteoradionecrosis for Head and Neck Patients in the IMRT/VMAT Era: Evidence From a Large, Hospital‐Based Cohort

Head &Neck, EarlyView.
ABSTRACT Purpose Osteoradionecrosis (ORN) of the jaw remains a serious late complication of head and neck cancer (HNC) radiotherapy. Although intensity‐modulated radiotherapy (IMRT) and volumetric‐modulated arc radiotherapy (VMAT) are expected to reduce ORN risk, large real‐world data in the modern era are limited.
Fang‐Yu Wu, Hui‐Hsin Ko, Hsiang‐Fong Kao, Shih‐Jung Cheng   +3 more
wiley   +1 more source

Editorial: Cholesteatoma surgery: treatment outcome and follow up. [PDF]

Front Surg
Thomeer H, Merkus P, Verhaert N, Lammers M.   +3 more
europepmc   +1 more source

External Validation of Pre‐Treatment Primary Tumor Volume as a Prognostic Factor in Head and Neck Cancer Treated With (Chemo)Radiotherapy

Head &Neck, EarlyView.
ABSTRACT Background Primary tumor volume (GTVp) is a key prognostic factor in oropharyngeal squamous cell carcinoma (OPSCC) treated with radiotherapy. We aimed to externally validate this association and assess its relevance in other head and neck sites.
Gabriel Adrian, Andre Haraldsson Änghede, Lachlan McDowell, Maria Gebre‐Medhin   +3 more
wiley   +1 more source

Poor Diet and Oral Cavity Cancer Risk in Smoking and Non‐Smoking Men and Women: An Analysis of Three US Cohorts

Head &Neck, EarlyView.
ABSTRACT Introduction Oral cavity cancer (OCC) incidence is rising among non‐smokers and younger individuals without traditional risk factors. While carcinogenic exposures such as tobacco and alcohol are well studied, the association between unhealthy dietary patterns and OCC has been minimally explored.
Mateo Useche, Luis Gomez‐Castillo, Kara Cushing‐Haugen, Rocco Ferrandino, Neal Futran, Emily Marchiano, Cristina P. Rodriguez, Holly R. Harris, Brittany Barber   +8 more
wiley   +1 more source

Correction to: RNF115 aggravates tumor progression through regulation of CDK10 degradation in thyroid carcinoma. [PDF]

Cell Biol Toxicol
Zhu J, Guo L, Dai H, Zheng Z, Yan J, Liu J, Zhang S, Li X, Sun X, Zhao Q, Xu C.   +10 more
europepmc   +1 more source